Magnetic microparticles selection for a new assay development

When developing a new chemiluminescence immunoassay (CLIA), it is fundamental to define and characterize, from the very early stages of the project, the key parameters that will define the new product. This would allow to reduce both risk and time during the development while increasing product robustness.

Among the key parameters to assess and characterize for CLIA development are the magnetic microparticles, from their selection to optimization of the protein coupling conditions.

Join us in the OEM series to learn how we proceed to define and characterize the right microparticle for a specific new CLIA development